Categories
Health

How the U.S. Reopening Would possibly Have an effect on Nervousness Sufferers

Now he says, “All of my interactions are virtual, so I don’t worry about handshakes and the awkwardness of the person.”

“When I go to bed at night I know what I’m going to do the next day and I’m not worried about it,” said Mr Bernoff. He loves the predictability of life – for example, when to have lunch and dinner and where it comes from. “I don’t like sounding paranoid, but I like being in the same place as my fridge.”

Mr Bernoff hurried to say he couldn’t wait for the pandemic to end – “and go to dinner with my wife.”

“I don’t want this to go on forever,” he added, “but just for this year, this time, it was a little island of stability.”

Mr. Bernoff is fortunate to work consistently; Research shows that anxiety and depression caused by the pandemic can disproportionately affect people with more shaky economic prospects. A large-scale study of 36,000 subjects in the UK, published in the December 2020 issue of The Lancet, found that mental health problems were increased in some people at the beginning of the lockdown and then decreased with some groups in general when the lockdown subsided more prone than others.

“Being women or younger, having a lower level of education, lower income, pre-existing mental illness, and living alone or with children were all risk factors for higher levels of anxiety and depressive symptoms at the start of lockdown,” the study noted firmly . The researchers found that this gradually subsided as people acclimatized and lockdown subsided.

In contrast, those stricken with anxiety who experienced relief during the pandemic are likely in higher income brackets, said Ms. Maikovich-Fong, the Denver therapist. They are more likely to have jobs that they can do remotely so they can keep busy, but with less stress than before.

Categories
Health

Studying to Take heed to Sufferers’ Tales

The pandemic has been a time of painful social isolation for many. Few places can be as isolating as hospitals, where patients are surrounded by strangers, subjected to invasive tests, and hooked up to a series of beep and gurgle machines.

How can the experience of receiving medical care be made more welcoming? Some say that having a sympathetic ear can go a long way in healing patients who are under the stress of hospitalization.

“It’s even more important now, when we can’t always see or touch patients’ faces, to really hear their stories,” said Dr. Antoinette Rose, an emergency doctor in Mountain View, California who now works with many patients sick with Covid.

“This pandemic has forced many caregivers to immerse themselves in the human stories that are playing out. They have no choice. They become “family” at the bedside, “said Dr. Andre Lijoi, medical director at York Hospital in Pennsylvania. Doctors, nurses, and others who assist with patient care “need time to slow down, take a breath, and listen”.

Both doctors find their inspiration in narrative medicine, a discipline that guides doctors in the art of listening deeply to those who come to them for help. Narrative medicine is taught in some form in approximately 80 percent of medical schools in the United States today. Students are trained in “sensitive interviewing skills” and the art of “radical listening” to improve the interaction between doctors and their patients.

“As doctors, we have to ask those who come to us, ‘Tell me about yourself,'” said Dr. Rita Charon, who founded Columbia University’s pioneering narrative medicine program in 2000. “We have fallen out of this habit because we think we know the questions we need to ask. We have a checklist of symptom questions. But there is an actual person in front of us who is not just a collection of symptoms.”

Columbia currently offers online training for medical students like Fletcher Bell, who says the course is helping to change the way he sees his future role as a healer. As part of his training as a storyteller, Mr. Bell stayed in virtual contact with a woman who was being treated for ovarian cancer. He described the experience of sharing as both heartbreaking and beautiful.

“It can be therapeutic just to listen to people’s stories,” noted Bell. “If there is fluid in the lungs, drain it. If there is a story in the heart, it is important to bring it out as well. It is also a medical intervention that is not easily quantified. “

This more personalized approach to medical care is not a new art. In the not too distant past, general practitioners often treated several generations of the same family and knew a lot about their lives. But as medicine became increasingly institutionalized it became faster and more impersonal, said Dr. Charon.

The typical doctor visit now takes 13 to 16 minutes, which is usually all insurance companies pay for. A 2018 study published in the Journal of General Internal Medicine found that the majority of doctors at the prestigious Mayo Clinic didn’t even ask people what the purpose of their visit was, and often interrupted patients talking about themselves.

Updated

Apr. 26, 2021, 1:26 p.m. ET

But this fast food approach to medicine is sacrificing something essential, says Dr. Deepu Gowda, assistant dean of medical education at Kaiser-Permanente School of Medicine in Pasadena, California, led by Dr. Charon was trained in Columbia.

Dr. Gowda recalls an elderly patient he saw during his stay who suffered from severe arthritis and whom he found angry and frustrated. He came to fear her office visits. Then he began to ask the woman questions, listening with interest as her personal story unfolded. He was so intrigued by her life story that he asked her permission to photograph her outside the hospital, which she granted.

Dr. Gowda was particularly impressed by a picture of his patient holding on to the railing of her walk-in apartment, stick in hand. “This picture represented their daily struggles for me,” he said. “I gave her a copy. It was a physical representation of the fact that I cared about who she was as a person. Her pain did not subside, but there was an ease and a laugh in those later visits that weren’t there before. There was some kind of healing that took place in this simple human appreciation. “

While few working doctors have the free time to photograph their patients outside of the clinic or delve deep into their life stories, “people pick it up” when the doctor shows genuine interest in them, said Dr. Gowda. You will trust such a doctor more and be motivated to follow their directions and return for follow-up visits, he said.

Some hospitals have started conducting preliminary interviews with patients before clinical work begins in order to get to know them better.

Thor Familler, a family therapist, started the My Life, My Story program in 2013 at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. Professional writers are hired to interview veterans – via telephone and videoconferencing since the pandemic outbreak – and compose a brief bio that is added to their medical record and read by their attending physician.

“My goal was to give veterinarians an opportunity to be heard in a large bureaucratic system in which they do not always feel heard,” said Ringler.

The program has expanded to 60 VA hospitals, including Boston, where over 800 veteran stories have been compiled over the past three years. Jay Barrett, nurse manager at VA Boston Healthcare System, said these biographies often provide important information that can serve as a guide to treatment.

“Unless they have access to the patient’s history,” Ms. Barrett said, “healthcare providers do not understand that this is a mother who looks after six children or who does not have the funds to pay for medication. ” or this is a veteran with severe trauma that needs to be addressed before even discussing how to deal with the pain. “

Dr. Lewis Mehl-Madrona, a family doctor who teaches at the University of New England in Biddeford, Maine, has examined veterans undergoing pain management. Those asked to share about their lives had less chronic pain and rated their relationship with their doctor higher than those who hadn’t. The doctors who requested the stories also reported greater job satisfaction and less emotional burnout, which has become a particularly worrying problem during the Covid pandemic.

The demands on the time of the healthcare workers have never been so high. However, proponents of narrative medicine say it takes only a few moments to establish an authentic human connection, even when the communication is online, as is often the case today. Dr. Mehl-Madrona argues that remote video conferencing platforms like Zoom can make it even easier to keep tabs on people at risk and solicit their stories.

Derek McCracken, a professor at Columbia University who helped develop training protocols for the use of storytelling in telemedicine, agrees. “Telehealth technology can be a bridge,” he said, “because it is a balance that forces both parties to slow down the conversation, be vulnerable, and listen carefully.”

The critical point for Dr. Flour madrona is that people asked to speak about themselves – whether in person or on screen – “don’t just throw themselves in to the doctor for repairs. They are actively involved in their own healing. “

“Doctors can be replaced by computers or nurses if they feel their only job is just to prescribe medication,” he added. “If we are to avoid the fate of the dodo bird, we need to establish dynamic relationships with patients and place symptoms in the context of people’s lives.”

Categories
Health

Vaccine Hesitancy in Most cancers Sufferers

Ideally, cancer patients who want the shot could get it in their cancer centers rather than a mass distribution location. But a bumpy rollout and age restrictions have frustrated many people with cancer. If the shot is offered, Dr. Brawley still has his patients in active therapy and those in follow-up care. Certainly, they may not react as strongly as someone with an intact immune system. They do receive some protection, however, and are not harmed, as Moderna and Pfizer’s current vaccines are not made from live viruses (like measles, rubella, mumps, and smallpox were). Live virus vaccines must be avoided by severely immunocompromised individuals.

Updated

Apr. 25, 2021, 9:04 p.m. ET

Moderna and Pfizer’s coronavirus vaccines, explains Dr. Brawley, are made from messenger ribonucleic acid (mRNA) using a new technology. Its genetic material causes the vaccinated person to produce the same proteins that are found in the spikes of the novel coronavirus.

“The vaccinated person’s immune system then recognizes these proteins as foreign and produces antibodies against them,” said Dr. Brawley. “Another immune cell, a dendritic cell, also records the proteins as foreign.”

Dr. William Nelson, director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, agreed that “the worst that can happen to cancer patients vaccinated with the coronavirus vaccine” is “a bad reaction.” The worst reactions are likely to occur in people dealing with B-cell lymphoma and multiple myeloma, he explained, since these therapies often use drugs that target antibody-producing cells in the body. “For people undergoing a bone marrow transplant,” advised Dr. Nelson, vaccinations should likely be scheduled three to six months after the transplant to ensure immune regeneration has occurred.

As important as the vaccines are, Dr. Nelson urged people with cancer as well as their families and friends to “remain vigilant when it comes to wearing masks, social distancing, hand washing, etc.” Because cancer patients often have low white blood cell counts, their symptoms – fever, muscle pain, headache, dry cough – cannot be distinguished from those of Covid-19. “Now these patients must also be quickly tested for the coronavirus and isolated in a suitable facility so that their intravenous antibiotics can be infused.”

When the health authorities in my state of Indiana announced that they would be vaccinating people over 70, I had no problem signing up for an appointment online. When I took my first shot in a small medical facility, it was full of people buoyed by high hopes for widespread, so-called herd immunity. My own optimism has been overshadowed by regular news this winter of maskless receptions, rallies, protests, parties, and raves, as well as personal conversations with people who fear vaccinations in general.

As Eula Biss explained in her brilliant prepandemic book On Immunity, fear of the government, the medical establishment, and public interference with the private establishment can stifle the collective trust that attaining immunity requires. Because cancer patients are often affected by anxiety, they may be particularly prone to these types of anxieties.

Categories
Business

New York well being chief defends state’s choice to make nursing houses take Covid sufferers

New York Health Commissioner Dr. Howard Zucker on Friday defended the state’s decision in March to force nursing homes to admit hospital residents with the coronavirus, blaming staff for spreading the virus.

The guideline, enacted on March 25, banned nursing homes from refusing admission or readmission to residents infected with Covid-19. The policy also banned nursing homes from testing patients prior to entry, NBC News reported. The policy was reversed later in May.

Zucker said Friday that at the time, the coronavirus hospitalization rate in New York was increasing “at an astounding rate” and capacity in the state’s intensive care units was running low. By allowing residents to return to the nursing homes, it helped protect the health system from collapse, he said.

“You can only verify a decision based on the facts you had at the time,” Zucker said during a press conference next to New York Governor Andrew Cuomo. “And with the facts we had at the time, it was the right decision from a public health perspective.”

Zucker said the decision was based on recommendations from the Centers for Disease Control and Prevention, issued at the time, that nursing homes should accept all residents who would normally accept them, including those diagnosed with Covid-19, for as long Precautions have been taken.

A CDC spokesman was not immediately available to comment on Zucker’s remarks.

“What if we hadn’t done it on March 25? Hospital beds, which ultimately saved lives, would not have been available because they would have been occupied by someone who could have been discharged,” Zucker said. “We made the right public health decision then and, given the same facts, we would make the same decisions again.”

The Covid-19 patients who returned to the nursing homes were likely not contagious according to the CDC’s guidelines at the time and were separated from other residents. Zucker added that state law requires nursing homes to refuse residents if they are unable to properly care for them.

“We simply said that you cannot refuse admission because of the Covid status,” he said. “We never said you had to accept, we said you couldn’t deny.”

The state’s top health official comes as the Cuomo government faces bipartisan criticism of the treatment of Covid-19 deaths in the nursing home. An investigation by New York Attorney General Letitia James published in late January found that the New York Department of Health signed up to 50% of deaths from Covid-19 in nursing homes.

On Friday, Cuomo and Zucker said most of the spread of the virus was not due to the Covid-positive resident, but from the staff who look after them.

“Covid came from the staff in the nursing homes. They got it at home, they got it at the supermarket, they went to work and they brought Covid with them,” Cuomo said.

However, Cuomo has aggressively defended the state’s census, stating that these deaths were counted as part of hospital deaths rather than nursing homes. The Democratic governor has apologized for “creating a void” by not providing enough information quickly enough and by not fighting against misinformation.

“Twitter, false reports, will eventually become a reality,” said Cuomo. “Social media, 24-hour news network, if you don’t correct it, it’ll repeat … and then people will think it’s true.”

In August, prosecutors under the Trump administration requested information about the deaths in New York nursing homes that Cuomo has criticized as politically motivated. The state legislature also asked for similar information, but the Cuomo government postponed that request to focus on that of the Justice Department, the governor said.

One of Cuomo’s top advisors, Melissa DeRosa, reportedly told Democratic lawmakers that the governor’s administration was “frozen” at their request because they feared the data would be used against them by the Justice Department, Associated Press reported.

DeRosa has since tried to clarify her comments, stating in a statement last week that she was trying to tell lawmakers that they need to focus on the Justice Department’s request first.

“We were comprehensive and transparent in our responses to the DOJ and had to immediately focus our resources on the introduction of the second wave and the vaccine,” DeRosa said in the statement. “As I said when I called the legislature, we weren’t able to respond to your request as quickly as anyone would have liked.”

Categories
Health

My Sufferers Want Me. Can I Give up?

I live in a city that offers Covid vaccines to volunteers who have worked at a vaccination site for 15 hours. Unsurprisingly, the demand for volunteer slots far exceeds supply. I got my first shot last week. I have more volunteer shifts planned for the next few weeks. Should I give these shifts to others so they can be vaccinated? Does the answer change when I’m sure my shifts are going to friends I know are also hardworking volunteers? I feel obliged to continue to volunteer because a) I don’t want to go away now that I have the vaccine; and b) even after just one shot, it is probably safer for me to interact with patients (who are old or otherwise at risk) than with someone who has not been vaccinated at all. However, I also feel obliged to have someone vaccinated. Elaine, Dallas

Your vaccination was done early not to get you to volunteer but to make your shifts safer for you and those you serve. Stopping undermines this purpose. You’re considering quitting so someone else can be vaccinated. But someone will get that dose, whatever you do. You asked yourself the question about the “duty to have someone vaccinated”. For example, suppose you asked if it was okay to play the system to favor one or two of your friends. I’m sure this prospect doesn’t suit you well.

Having special weight on you and your friends doesn’t mean you can ignore the moral demands of others.

According to the logic of this “duty” that you claim, each of your hardworking friends should spend as little time as possible on site to get vaccinated and then pass the opportunity on to someone else. Indeed, your job is to do your job and acknowledge that the vaccination program does not exist for the benefit of those who work there. Volunteering was a gift; However, if you see work as a means of vaccinating friends who otherwise don’t qualify, you run the risk of becoming the handle. They would only distract vaccine doses from people who have been declared eligible by a vaccine distribution system designed to achieve a variety of goals. Allowing people who work at a vaccination site to have special treatment for their friends is not one of those goals.

In my state, and possibly elsewhere, food bank volunteers are given priority access to coronavirus vaccines. Is it ethically correct to volunteer at a food bank to get vaccinated earlier? Name withheld, Somerville, Mass.

The best kind of people doing what is right for the best of reasons. The moral saint would selflessly volunteer to the food bank as a way of serving the disadvantaged in her community. You admit that you are not the perfect person. But volunteering for the food bank, even if for less than admirable reasons, is still a good thing. Once again, vaccination is no reward for this good deed; There is a need to reduce the chances of people (including you) getting infected in the food bank. However, it can also be an incentive to sign up, as people in your community obviously know, and in those circumstances, it is not very likely that you will receive a lot of undeserved praise for showing up. Then, if you thought up the job of carousel among your otherwise vaccine-free friends, you would be abusing the agreement. If your motives are selfish, make sure your actions are overboard.

Kwame Anthony Appiah teaches philosophy at NYU. His books include Cosmopolitanism, The Honor Code, and The Lies That Bind: Rethinking Identity. To submit a request: send an email to ethicist@nytimes.com; or email The Ethicist, New York Times Magazine, 620 Eighth Avenue, New York, NY 10018. (Provide a phone number for the day.)

Categories
Health

Roche arthritis drug reduces loss of life in hospitalized sufferers with extreme Covid, Oxford researchers say

A pharmacist shows a box of tocilizumab, which is used to treat rheumatoid arthritis, in the pharmacy of Cambrai Hospital in France on April 28, 2020.

Pascal Rossignol | Reuters

A drug used to treat people with rheumatoid arthritis appears to reduce the risk of death in hospitalized patients with severe Covid-19, especially when combined with the steroid dexamethasone, Oxford University researchers said Thursday.

Oxford researchers found that the drug tocilizumab, an intravenous drug of A department of the Swiss drug manufacturer Roche also shortened the length of stay for patients in hospitals and reduced the need for a ventilator. The study was part of the recovery study, which has tested a number of potential treatments for Covid-19 since March.

“Previous studies of tocilizumab had shown mixed results and it was unclear which patients might benefit from the treatment,” said Peter Horby, professor at Oxford University and co-investigator for the recovery study, in a statement. “We now know that tocilizumab benefits apply to all COVID patients with low oxygen levels and significant inflammation.”

A total of 2,022 patients were randomly selected to receive tocilizumab, sold under the brand name Actemra, by intravenous infusion and compared to 2,094 patients who were randomly selected to receive standard care alone. The researchers said 82% of patients were also taking a steroid like dexamethasone, another drug that was found to reduce deaths in the sickest Covid-19 patients.

Researchers said 596 patients in the tocilizumab group died within 28 days, compared with 694 patients in the standard care group. That means that for every 25 patients treated with tocilizumab, “an extra life would be saved,” said Oxford researchers.

The drug increased the chances of being discharged from 47% to 54% within 28 days, the researchers said. The benefits have been seen in all patients, including those who need mechanical ventilators in an intensive care unit, they added. In patients who were not given a ventilator prior to the start of the study, tocilizumab reduced the chance of getting invasive mechanical ventilation or death from 38% to 33%, the researchers said.

The researchers said that using tocilizumab in combination with dexamethasone reduced mortality by about a third in patients who require oxygen and by almost half in patients who require a ventilator.

The results of the Oxford study have not yet been published in a peer-reviewed journal.

Public health officials and infectious disease experts say world leaders will need a range of drugs and vaccines to end the pandemic that, according to Johns, will infect more than 107.4 million people in just over a year and has killed at least 2.3 million people at Hopkins University.

In the US, the Food and Drug Administration has approved Gilead Sciences’ antiviral drug Remdesivir for the treatment of Covid-19 patients who are 12 years or older and require hospitalization.

The FDA has approved the use of two monoclonal antibody treatments as well as two vaccines – from Pfizer and Moderna. A third vaccine from Johnson & Johnson is expected to receive FDA approval as early as this month.

The Covid-19 Therapy Randomized Evaluation, or Recovery Study, was launched in March by researchers at Oxford University to find treatments for Covid-19. The study previously showed that hydroxychloroquine, lopinavir ritonavir, azithromycin, and convalescent plasma had no benefits for patients hospitalized with Covid-19.

The study is currently investigating aspirin, the anti-inflammatory drugs baricitinib and colchicine, and Regeneron’s antibody cocktail.

Categories
Health

Medical specialists attempt to set up ‘lengthy Covid’ analysis for sufferers with lasting signs

Critical care carers insert an endotracheal tube into a patient with coronavirus disease (COVID-19) in the intensive care unit (ICU) at Sarasota Memorial Hospital in Sarasota, Florida on February 11, 2021.

Shannon Stapleton | Reuters

Some Covid-19 patients suffer from shortness of breath, fatigue, headaches and “brain fog” for months to almost a year after their first illness. Now global medical experts are working to better diagnose and treat what they tentatively refer to as “long covid”.

Earlier this week, the World Health Organization hosted a global meeting with “patients, clinicians and other stakeholders” to improve the agency’s understanding of the post-Covid medical condition, also known as Long Covid, WHO director general Tedros Adhanom Ghebreyesus said Friday.

The meeting was the first of many to come. The goal will ultimately be to produce an “agreed clinical description” of the disease so that doctors can diagnose and treat patients effectively, he said. Given the number of people infected with the virus worldwide – nearly 108 million people as of Friday – Tedros warned that many of these persistent symptoms are likely to appear.

“This disease affects patients with severe and mild Covid-19,” Tedros said during a press conference at the agency’s headquarters in Geneva. “Part of the challenge is that long-term Covid patients can have a range of different symptoms that can be persistent or come and go.”

Limited dates

So far, there have been a limited number of studies that will determine what symptoms are most common and how long they might last. The main focus was on people with a serious or fatal illness, not people who have recovered but still report persistent side effects, sometimes referred to as “long distance riders”.

Most Covid patients are believed to recover only weeks after their initial diagnosis, but some have symptoms for six months or even almost a year, medical experts say.

One of the largest global studies on Long Covid, published in early January, found that many people who have persistent illness after infection cannot work full-time six months later. The study, published on MedRxiv and not peer reviewed, interviewed more than 3,700 people, ages 18 to 80, from 56 countries to identify symptoms.

The most common symptoms after six months were fatigue, post-exercise fatigue, and cognitive dysfunction, sometimes called brain fog.

Is that unique to Covid-19?

“We really don’t know what is causing these symptoms. That is a focus of research right now,” said Dr. Allison Navis, a professor at the Icahn School of Medicine at Mount Sinai, during a call to the Infectious Diseases Society of America on Friday.

“The question that arises is whether this is something that is unique to Covid itself – and it is the Covid virus that is causing these symptoms – or whether this could be part of a general post-viral syndrome,” Navis said, adding, that medical experts see similar long-term symptoms after other viral infections.

Another study, published in the medical journal The Lancet in early January, looked at 1,733 patients discharged from a hospital in Wuhan, China, between January and May last year. Of these patients, 76% reported at least one symptom six months after their first illness. The proportion was higher among women.

“We found that fatigue or muscle weakness, sleep disorders, and anxiety or depression were common even 6 months after symptoms appeared,” the researchers wrote in the study.

They found that symptoms reported months after the Covid-19 diagnosis was consistent with data previously found in follow-up studies of Severe Acute Respiratory Syndrome (SARS), a coronavirus.

Post-Covid clinics are going online

Some large medical centers are currently setting up post-Covid clinics to care for patients with persistent symptoms. Navis said her clinic on Mount Sinai, New York treated a “fairly even” distribution of men and women with persistent illness, and the average age of patients was 40 years.

Dr. Kathleen Bell, a professor at the University of Texas’ Southwestern Medical Center, said her hospital’s long-term Covid-19 clinic began last April when a wave of infections hit Italy and New York at the start of the pandemic.

Bell said on the Infectious Diseases Society of America conference call on Friday that a number of professionals are required to staff the clinics because symptoms are uneven, including experts who can treat muscle weakness, heart-related disorders, and cognitive problems in the insane and health Problems after their diagnosis.

“It forces all of us, in many ways, to come together and make sure we have open lines of communication to address all of these issues for patients,” said Bell.

Bell added that the Centers for Disease Control and Prevention held a phone call in January with long Covid centers across the country to discuss their model for treating patients.

“I think the CDC is now trying to bring centers together and get some firmer guidelines on it, which is very exciting,” said Bell.

– CNBC’s Sam Meredith contributed to this report.

Categories
Business

Recovered Covid sufferers have been reinfected with new virus strains, WHO says

A laboratory technician tests material with a single-channel pipette dropper during processing of the Covid-19 polymerase chain reaction test (PCR) in a laboratory in the South African suburb of Dunkeld in Johannesburg, South Africa on Wednesday, February 10, 2021.

Waldo Swiegers | Bloomberg | Getty Images

Preliminary reports from South Africa show that people who have recovered from Covid-19 have been re-infected with a new, contagious variant of the virus, World Health Organization officials said at a news conference on Friday.

The good news, however, is that vaccines designed to protect against the virus appear to reduce the severity of the disease in those who develop Covid-19, even if they don’t completely protect them from infection, the chief scientist said the WHO, Dr. Soumya Swaminathan.

“The [vaccine] Studies that have so far been carried out in South Africa as well as in Brazil with various candidates have shown complete protection against serious illness, hospitalization and death. A single case was not reported in any of the studies, “she said.

According to the WHO, vaccination can also reduce the spread of new Covid variants.

“There are now reports that when you have the vaccine and you get infected, the viral load is much lower, so you may be less likely to infect others,” Swaminathan said.

Previous Covid infection creates antibodies and cell-mediated immunity that are believed to prevent re-infection, scientists have found. Vaccination also helps individuals build protection against the virus.

However, the researchers are still investigating the extent to which prior infection and vaccination will protect against the new, more infectious variants of the coronavirus.

Increased vaccination efforts alone are unlikely to be enough to control the spread of the UK-native strain of coronavirus, said Dr. Scott Gottlieb, former Commissioner of the Food and Drug Administration, told CNBC on Thursday. Gottlieb said a combination of incoming warmer weather and increased vaccinations could help contain the variant.

Swaminathan at the WHO briefing on Friday stressed the importance of vaccinated people continuing to take precautions such as wearing masks, hand washing and social distancing to control the spread of the virus.

Categories
Health

Semaglutide Brings Vital Weight Loss in Overweight Sufferers

For the first time, a drug has been shown to be so effective against obesity that patients can avoid many of its worst effects, including diabetes, researchers reported Wednesday.

Novo Nordisk’s drug Semaglutide is already marketed for the treatment of type 2 diabetes. In a clinical study published in the New England Journal of Medicine, researchers at Northwestern University in Chicago tested semaglutide at a much higher dose as an anti-obesity drug.

Nearly 2,000 participants in 129 centers in 16 countries injected semaglutide or a placebo weekly for 68 weeks. Those who received the drug lost an average of nearly 15 percent of their body weight, compared with 2.4 percent of those who received the placebo.

More than a third of the participants who received the drug lost more than 20 percent of their weight. Symptoms of diabetes and pre-diabetes improved in many patients.

These results far exceed the weight loss seen in clinical trials with other anti-obesity drugs, experts say. The drug is a “game changer,” said Dr. Robert F. Kushner, an obesity researcher at Northwestern University’s Feinberg School of Medicine, who led the study. “This marks the beginning of a new era of effective obesity treatments.”

Dr. Clifford Rosen of the Maine Medical Center Research Institute, who was not involved in the study, said, “I think it has great potential for weight loss.” The gastrointestinal symptoms among the participants were “really marginal – nothing like weight loss drugs in the past,” added Dr. Rosen, editor of the New England Journal of Medicine and co-author of an editorial that accompanied the study.

For decades, scientists have been looking for ways to help a growing number of people with obesity. Five obesity drugs currently available have side effects that limit their use. The most effective phentermine causes an average weight loss of 7.5 percent and can only be taken for a short time. After stopping, this amount of weight is also regained.

The most effective treatment to date is bariatric surgery, which allows people to lose an average of 25 to 30 percent of their body weight, noted Dr. Louis Aronne, an obesity researcher at Weill Cornell Medicine in New York, who advises Novo Nordisk and studies semaglutide.

However, surgery is an invasive solution that permanently changes the digestive system. Only 1 percent of those who qualify do the procedure. Instead, most obese people try diet after diet with disappointing results.

The semaglutide study confirms what scientists already know, said Dr. Kushner: Willpower is not enough. In the new study, the participants who received the placebo and the diet and exercise counseling could not find any significant difference in weight.

In general, insurers have refused to pay for the weight loss drugs on the market. Semaglutide is likely to be expensive. The lower dose used to treat diabetes has an average retail price of nearly $ 1,000 per month. (Insurers usually pay for diabetes medication, Dr. Kushner noted.)

Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital and a member of the Novo Nordisk advisory board, said semaglutide’s effectiveness is “phenomenal” and the trial results may lead insurers to cover it.

Semaglutide is a synthetic version of a naturally occurring hormone that acts on appetite centers in the brain and intestines, causing feelings of satiety. A high-dose regimen of the drug hasn’t been studied long enough to see if it has serious long-term effects.

And it is expected that patients will have to take it for a lifetime to prevent weight loss from returning.

Qiana Mosely, who lives in Chicago, has tried dieting and drugs for years to lose weight, but to no avail. Then Ms. Mosely took the semaglutide study and lost 40 pounds, about 15 percent of her weight.

Ms. Mosely did not know until recently whether she was receiving the drug or the placebo. Although she tried to eat well and exercise, her weight “dropped too quickly,” she said. “It had to be the drugs.”

She said she didn’t experience any side effects. But when the study ended and she stopped receiving the drug, the weight came back. “I was so sad,” she said. She will endeavor to resume taking the medicine as soon as it becomes available.

Categories
Health

Within the Vaccine Scramble, Most cancers Sufferers Are Left Behind

“This was a complete – I’m not going to say disaster, but it was pretty close,” said Dr. Hanny Al-Samkari, hematologist and clinical investigator at Massachusetts General Hospital and Harvard Medical School. Cancer patients get “mixed news,” he said, and the guidance they receive depends largely on their condition. Every day, he receives a barrage of messages from patients asking if they still qualify for the vaccine (in his state the answer is mostly no). They drove four hours to find a vaccination site. “It’s the Wild West,” he said.

He urged cancer patients to contact their doctors to coordinate the timing of the vaccine according to their treatment, unless they are in remission, have been treated a long time ago, or are receiving only hormonal treatment for breast or breast cancer Prostate cancer, said Dr. Tomasz Beer, professor in the School of Medicine at Oregon Health and Science University and assistant director of the school’s Knight Cancer Institute.

Covid19 vaccinations>

Answers to your vaccine questions

Am I eligible for the Covid vaccine in my state?

Currently more than 150 million people – almost half of the population – can be vaccinated. But each state makes the final decision on who goes first. The country’s 21 million healthcare workers and three million long-term care residents were the first to qualify. In mid-January, federal officials asked all states to open eligibility to anyone over 65 and adults of any age with medical conditions that are at high risk of becoming seriously ill or dying of Covid-19. Adults in the general population are at the end of the line. If federal and state health authorities can remove bottlenecks in the distribution of vaccines, everyone over the age of 16 is eligible as early as spring or early summer. The vaccine has not been approved in children, although studies are ongoing. It can take months before a vaccine is available to anyone under the age of 16. For the latest information on vaccination guidelines in your area, see your state health website

Is the Vaccine Free?

You shouldn’t have to pay anything out of pocket to get the vaccine, despite being asked for insurance information. If you don’t have insurance, you should still get the vaccine for free. Congress passed law this spring banning insurers from applying cost-sharing such as a co-payment or deductible. It consisted of additional safeguards prohibiting pharmacies, doctors, and hospitals from charging patients, including uninsured patients. Even so, health experts fear that patients will end up in loopholes that make them prone to surprise bills. This may be the case for people who are charged a doctor’s visit fee with their vaccine, or for Americans who have certain types of health insurance that are not covered by the new regulations. When you get your vaccine from a doctor’s office or emergency clinic, talk to them about possible hidden costs. To make sure you don’t get a surprise invoice, it is best to get your vaccine from a Department of Health vaccination center or local pharmacy as soon as the shots become more widely available.

Can I choose which vaccine to get?How long does the vaccine last? Do I need another next year?

That is to be determined. It is possible that Covid-19 vaccinations will become an annual event just like the flu vaccination. Or the vaccine may last longer than a year. We’ll have to wait and see how durable the protection from the vaccines is. To determine this, researchers will track down vaccinated people to look for “breakthrough cases” – those people who get Covid-19 despite being vaccinated. This is a sign of a weakening of protection and gives researchers an indication of how long the vaccine will last. They will also monitor the levels of antibodies and T cells in the blood of people who have been vaccinated to see if and when a booster shot might be needed. It is conceivable that people might need boosters every few months, once a year, or just every few years. It’s just a matter of waiting for the data.

Does my employer need vaccinations?Where can I find out more?

For example, those receiving chemotherapy might have the best chances of developing an immune response if the vaccine is given if their white blood cell counts aren’t at their lowest levels, said Dr. Beer. The recommendations for patients with leukemia or lymphoma who are under treatment or who have recently had a bone marrow transplant are particularly complex and absolutely require consultation and coordination with an oncologist, he stressed.

While some are concerned about the risk of encountering a crowd at a mass vaccination site, Dr. Al-Samkari instructs patients to receive doses wherever they are available, as long as they wear masks and keep their distance from other people. “Fears are clearly well founded,” he said. “But we have to get shots in the arms.”

In general, people with cancer should get the vaccine “as soon as possible, wherever they can,” said Dr. Carol Ann Huff, clinical director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and one of the authors of the Cancer Network’s National Comprehensive Guidelines on Covid-19 Vaccines for Cancer Patients. There are some caveats: Patients on a bone marrow transplant or CAR-T therapy should wait at least three months before receiving the vaccine, she said.

However, depending on the level of virus transmission in the patient community, it may be safer to wait to receive the vaccine. If there is high levels of transmission in the community, “the risks might outweigh the benefits of waiting,” said Dr. Beer. Patients with active cancer should contact their oncologist before receiving the vaccine. He advised unless they are in remission, have been treated a long time ago, or are just receiving hormonal treatment for breast or prostate cancer.

Those who take part in cancer clinical trials have a grimmer guide to vaccination. Allyson Harkey, 46, from Maryland, has stage four kidney cancer and is in an immunotherapy study. She said her doctor wasn’t sure she should get the vaccine. The National Comprehensive Cancer Network guidelines generally recommend that patients receiving immunotherapy receive the vaccine as soon as it becomes available. However, you should consult with your doctor beforehand as there are so many different studies out there. She feels like she is in a state of limbo, waiting for more information – a process made more frustrating by what she thinks is a ticking clock. “My prognosis is not good. I probably have a few more years, ”she said. “It’s really hard to spend this time because I know I don’t have much time left, just in my house.”